These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31004967)

  • 1. Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study.
    Cebolla JJ; Irún P; Mozas P; Giraldo P
    Atherosclerosis; 2019 Jun; 285():49-54. PubMed ID: 31004967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study.
    De Castro-Orós I; Irún P; Cebolla JJ; Rodriguez-Sureda V; Mallén M; Pueyo MJ; Mozas P; Dominguez C; Pocoví M;
    J Transl Med; 2017 Feb; 15(1):43. PubMed ID: 28222799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
    Poinsot P; Collardeau Frachon S; Restier L; Sérusclat A; Di Filippo M; Charrière S; Moulin P; Lachaux A; Peretti N
    J Clin Lipidol; 2017; 11(1):167-177.e3. PubMed ID: 28391883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?
    Chora JR; Alves AC; Medeiros AM; Mariano C; Lobarinhas G; Guerra A; Mansilha H; Cortez-Pinto H; Bourbon M
    J Clin Lipidol; 2017; 11(2):477-484.e2. PubMed ID: 28502505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestane-3β, 5α, 6β-triol: Further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C.
    Cooper JA; Church HJ; Wu HY
    Mol Genet Metab; 2020 May; 130(1):77-86. PubMed ID: 32178982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.
    Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U
    Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
    Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS;
    J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
    Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
    Cappuccio G; Donti TR; Hubert L; Sun Q; Elsea SH
    J Inherit Metab Dis; 2019 May; 42(3):509-518. PubMed ID: 30684275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
    Boot RG; Verhoek M; de Fost M; Hollak CE; Maas M; Bleijlevens B; van Breemen MJ; van Meurs M; Boven LA; Laman JD; Moran MT; Cox TM; Aerts JM
    Blood; 2004 Jan; 103(1):33-9. PubMed ID: 12969956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on lysosomal acid lipase deficiency: Diagnosis, treatment and patient management.
    Camarena C; Aldamiz-Echevarria LJ; Polo B; Barba Romero MA; García I; Cebolla JJ; Ros E
    Med Clin (Barc); 2017 May; 148(9):429.e1-429.e10. PubMed ID: 28285817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry.
    Balwani M; Balistreri W; D'Antiga L; Evans J; Ros E; Abel F; Wilson DP
    Liver Int; 2023 Jul; 43(7):1537-1547. PubMed ID: 37222260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.
    Reiner Ž; Guardamagna O; Nair D; Soran H; Hovingh K; Bertolini S; Jones S; Ćorić M; Calandra S; Hamilton J; Eagleton T; Ros E
    Atherosclerosis; 2014 Jul; 235(1):21-30. PubMed ID: 24792990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population.
    Irún P; Cebolla JJ; López de Frutos L; De Castro-Orós I; Roca-Espiau M; Giraldo P
    Clin Chem Lab Med; 2020 Apr; 58(5):798-809. PubMed ID: 32126008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for lysosomal acid lipase deficiency: A retrospective data mining study and evaluation of screening criteria.
    Draijer LG; Bosch AM; Wiegman A; Sjouke B; Benninga MA; Koot BGP
    Atherosclerosis; 2018 Nov; 278():174-179. PubMed ID: 30286343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
    Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
    Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency.
    Pritchard AB; Strong A; Ficicioglu C
    Orphanet J Rare Dis; 2020 Feb; 15(1):58. PubMed ID: 32093730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel synonymous variant in LIPA gene affects splicing and causes lysosomal acid lipase deficiency.
    Bychkov IO; Kamenets EA; Filatova AY; Skoblov MY; Mikhaylova SV; Strokova TV; Gundobina OS; Zakharova EY
    Mol Genet Metab; 2019 Jul; 127(3):212-215. PubMed ID: 31230978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.